Maternal Fatty Acid Status and Infant Epigenetic Aging Biomarkers in Buccal Swabs: Results from the APrON Study
Nutrients · 19.11.2026 · 18 (22) · 3854
DOI: 10.3390/nu18223854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 19.11.2026. Verfasst von Andrea Gretchev und 9 weiteren Autor:innen. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alberta Innovates Health Solutions, Alberta Children’s Hospital Foundation, Alberta Children’s Hospital Research Institute.
Abstract (Originalsprache)
Background
Maternal fatty acids are essential for fetal development and may influence infant aging biomarkers estimated using epigenetic clocks.
Objective
This observational study examined associations between maternal serum phospholipid fatty acid status during pregnancy and infant epigenetic aging biomarkers in buccal epithelial cells (BECs).
Methods
Participants included 246 mother-infant pairs from the Canadian APrON cohort. Serum phospholipid fatty acid relative percentages were determined from maternal second-trimester blood samples. Buccal swabs were collected from 3-month-old infants, from which BEC DNA methylation was profiled using the Infinium MethylationEPIC v1.0 BeadChip. A common aging biomarker, epigenetic age acceleration (EAA), was calculated using the Pediatric-Buccal-Epigenetic (PedBE) clock by taking the residual derived from a linear regression of DNA methylation-based age on chronological age, corrected for estimated BEC proportion. Multivariable robust linear regression models examined associations between maternal fatty acid relative percentages and infant EAA.
Results
Maternal eicosapentaenoic acid (β = 1.55, 95% CI: 0.24, 2.87) and total omega-3 fatty acids (β = 0.36; 95% CI: 0.02, 0.70) were positively associated with infant PedBE EAA. An inverse association was observed between the omega-6 to omega-3 fatty acid ratio and PedBE EAA (β = −0.24; 95% CI: −0.48, −0.01).
Conclusions
Maternal serum phospholipid fatty acid composition during pregnancy was associated with infant EAA, with different associations observed across individual fatty acids and measures of fatty acid balance. Further research is needed to understand the developmental significance of epigenetic aging deviations during infancy and the potential implications of maternal fatty acid status for early-life biological aging.
Förderung
- Alberta Innovates Health Solutions
- Alberta Children’s Hospital Foundation
- Alberta Children’s Hospital Research Institute
- Canadian Institutes of Health Research
Zitieren
APA
Gretchev, A., Temples, H. S., Sarasua, S. M., Haley-Zitlin, V., Field, C. J., Merrill, S. M., MacIssac, J. L., Kobor, M. S., Dewey, D., & England-Mason, G. (2026). Maternal Fatty Acid Status and Infant Epigenetic Aging Biomarkers in Buccal Swabs: Results from the APrON Study. Nutrients, 18(22), 3854. https://doi.org/10.3390/nu18223854
Vancouver
Gretchev A, Temples HS, Sarasua SM, Haley-Zitlin V, Field CJ, Merrill SM, et al. Maternal Fatty Acid Status and Infant Epigenetic Aging Biomarkers in Buccal Swabs: Results from the APrON Study. Nutrients. 2026;18(22):3854. doi:10.3390/nu18223854
BibTeX
@article{Gretchev2026,
author = {Gretchev, Andrea and Temples, Heide S. and Sarasua, Sara M. and Haley-Zitlin, Vivian and Field, Catherine J. and Merrill, Sarah M. and MacIssac, Julia L. and Kobor, Michael S. and Dewey, Deborah and England-Mason, Gillian},
title = {Maternal Fatty Acid Status and Infant Epigenetic Aging Biomarkers in Buccal Swabs: Results from the APrON Study},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {22},
pages = {3854},
doi = {10.3390/nu18223854}
}
EUVIMED